The states with the highest rates of HIV diagnoses in 2021 included Georgia, Louisiana, and Florida. However, the states with the highest number of people with HIV were California, Texas, and Florida. In California, there were around 4,399 people diagnosed with HIV. HIV/AIDS diagnoses The number of diagnoses of HIV/AIDS in the United States has continued to decrease in recent years. In 2021, there were an estimated 35,769 HIV diagnoses in the U.S. down from 38,433 diagnoses in the year 2017. In total, since the beginning of the epidemic in 1981 there have been around 1.25 million diagnoses in the United States. Deaths from HIV Similarly, the death rate from HIV has also decreased significantly over the past few decades. In 2019, there were only 1.4 deaths from HIV per 100,000 population, the lowest rate since the epidemic began. However, the death rate varies greatly depending on race or ethnicity, with the death rate from HIV for African Americans reaching 19.1 per 100,000 population in 2020.

United States US: Incidence of HIV: per 1,000 Uninfected Population data was reported at 0.110 Ratio in 2019. This stayed constant from the previous number of 0.110 Ratio for 2018. United States US: Incidence of HIV: per 1,000 Uninfected Population data is updated yearly, averaging 0.120 Ratio from Dec 2010 (Median) to 2019, with 10 observations. The data reached an all-time high of 0.130 Ratio in 2012 and a record low of 0.110 Ratio in 2019. United States US: Incidence of HIV: per 1,000 Uninfected Population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates.;Weighted average;This is the Sustainable Development Goal indicator 3.3.1 [https://unstats.un.org/sdgs/metadata/].

In 2021, the states with the highest number of HIV diagnoses were California, Texas, and Florida. That year, there were a total of around 35,716 HIV diagnoses in the United States. Of these, 4,399 were diagnosed in California. HIV infections have been decreasing globally for many years. In the year 2000, there were 2.8 million new infections worldwide, but this number had decreased to around 1.3 million new infections by 2023. The number of people living with HIV remains fairly steady, but the number of those that have died due to AIDS has reached some of its lowest peaks in a decade. Currently, there is no functional cure for HIV or AIDS, but improvements in therapies and treatments have enabled those living with HIV to have a much improved quality of life.

In Italy, the total number of newly diagnosed HIV (human immunodeficiency virus) infections peaked in 2012, when 4,180 new cases were recorded. Thereafter, the number gradually decreased until 2020, when 1,470 individuals were newly diagnosed with HIV, to rise again in 2021, 2022, and 2023. This virus is responsible for AIDS (acquired immunodeficiency syndrome), which is a condition that remarkably weakens the immune system, making the contraction of diseases much more likely. HIV incidence worldwide In 2023, roughly 39.9 million people suffered from HIV worldwide. The number of people living with HIV steadily grew from 2000 to 2023. Nonetheless, the number of new HIV infections decreased over time.  HIV epidemiology in Italy In Italy, the regions of Lombardy, Lazio, and Emilia-Romagna were the ones with the highest number of people newly diagnosed with HIV in 2023. The virus was mainly prevalent among males aged 30 to 49 years old during this same period. Indeed, 501 men aged between 30 and 39 years, and 449 between 40 and 49 years old, were newly diagnosed with HIV.  

Forecast: Number of New HIV Infections in the US 2023 - 2027 Discover more data with ReportLinker!

Series Name: Number of new HIV infections per 1 000 uninfected population by sex and age (per 1 000 uninfected population)Series Code: SH_HIV_INCDRelease Version: 2021.Q2.G.03 This dataset is the part of the Global SDG Indicator Database compiled through the UN System in preparation for the Secretary-General's annual report on Progress towards the Sustainable Development Goals.Indicator 3.3.1: Number of new HIV infections per 1,000 uninfected population, by sex, age and key populationsTarget 3.3: By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseasesGoal 3: Ensure healthy lives and promote well-being for all at all agesFor more information on the compilation methodology of this dataset, see https://unstats.un.org/sdgs/metadata/

Annual number of new HIV infections per 1,000 uninfected population

This data set includes tables on persons living with HIV/AIDS, newly diagnosed HIV cases and all cause deaths in HIV/AIDS cases by gender, age, race/ethnicity and transmission category. In all tables, cases are reported as of December 31 of the given year, as reported by January 9, 2019, to allow a minimum of 12 months reporting delay. Gender is determined by both current gender and sex at birth variables; transgender values are assigned when current gender is identified as "Transgender" or when a discrepancy is identified between a person's sex at birth and their current gender (e.g., cases where sex at birth is "Male" and current gender is "Female" will become Transgender: Male to Female.) Prior to 2003, Asian and Native Hawaiian/Pacific Islanders were classified as one combined group. In order to present these race/ethnicities separately, living cases recorded under this combined classification were split and redistributed according to their expected proportional population representation estimated from post-2003 data.

These data were reported to the NYC DOHMH by March 31, 2021 This dataset includes data on new diagnoses of HIV and AIDS in NYC for the calendar years 2016 through 2020. Reported cases and case rates (per 100,000 population) are stratified by United Hospital Fund (UHF) neighborhood, sex, and race/ethnicity. Note: - Cells marked "NA" cannot be calculated because of cell suppression or 0 denominator.

Data Series: Number of new HIV infections per 1,000 uninfected population, by sex, age and key populations Indicator: III.8 - Number of new HIV infections per 1,000 uninfected population, by sex, age and key populations Source year: 2022 This dataset is part of the Minimum Gender Dataset compiled by the United Nations Statistics Division. Domain: Health and related services

Laos LA: Incidence of HIV: per 1,000 Uninfected Population data was reported at 0.140 Ratio in 2022. This stayed constant from the previous number of 0.140 Ratio for 2021. Laos LA: Incidence of HIV: per 1,000 Uninfected Population data is updated yearly, averaging 0.150 Ratio from Dec 1990 (Median) to 2022, with 33 observations. The data reached an all-time high of 0.170 Ratio in 2013 and a record low of 0.010 Ratio in 1993. Laos LA: Incidence of HIV: per 1,000 Uninfected Population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Laos – Table LA.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates.;Weighted average;This is the Sustainable Development Goal indicator 3.3.1 [https://unstats.un.org/sdgs/metadata/].

This statistic depicts the total number of annual new HIV infections worldwide from 2000 to 2023. UNAIDS estimated that there were some 1.3 million people worldwide that were newly infected with HIV in 2023. Total number of new HIV infections worldwideHuman immunodeficiency virus (HIV) is a condition that slowly destroys or impairs the body’s immune system. It is a retrovirus that slowly progresses through the various stages of the disease. As HIV reproduces, it mutates its structure, which makes it difficult to treat through drug therapy. Around 39.9 million people were living with HIV worldwide as of 2023 with some 30.7 million people accessing ART treatment. There are various types of ways to treat HIV. Antiviral treatment has been on the decline as combination therapy such as fixed-dose combinations become more popular. New HIV infections worldwide have been on the decline since 2000 from 2.8 million new infections to 1.3 million new infections in 2023. Many new infections occur in developing countries, especially those in low- and middle-income countries in Sub-Saharan Africa. Many of these individuals have no access to drugs or treatment that can make living with HIV more manageable. Children are also susceptible to infection, often from HIV-positive mothers during pregnancy, childbirth, or breastfeeding. There are approximately 1.4 million children living with HIV globally.

Estimated incidence rate (new HIV infection per 1,000 uninfected population, children aged 0-14 years)

According to Cognitive Market Research, the global HIV Diagnostics market size is USD 4158.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 10.90% from 2024 to 2031. North America held the major market share for more than 40% of the global revenue with a market size of USD 1663.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031. Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1247.46 million. Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 956.39 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.9% from 2024 to 2031. Latin America had a market share of more than 5% of the global revenue with a market size of USD 207.91 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2031. Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 83.16 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.6% from 2024 to 2031. Consumables held the highest HIV Diagnostics market revenue share in 2024. Market Dynamics of HIV Diagnostics Market Key Drivers for HIV Diagnostics Market Increasing Prevalence of Sexually Transmitted Disease to Increase the Demand Globally Throughout the many decades of the HIV pandemic, the number of infected individuals is continually rising. The socioeconomic variables driving this continuous increase also suggest that preventative measures have not been successful. Even though many of these infections are preventable, there are an estimated 20 million new cases of STDs in the US each year, and the rate is still rising. Moreover, there are over 1.2 million HIV-positive individuals residing in the United States. Attempts to encourage testing and screening for sexually transmitted infections can ascertain an individual's likelihood of acquiring one and help those who already have one receive treatment, so enhancing their health and lowering the danger of HIV spreading to others. Approximately 38.4 million people worldwide were HIV positive in 2021. Among these, women and girls made up nearly 54%. Rising Initiatives by Global Agencies to Propel Market Growth HIV is among the world's most important public health concerns. As a result, there is a global commitment to stopping new HIV infections and giving everyone on the planet access to HIV therapy. WHO recommends testing for HIV to anyone who might be at risk. The World Bank was a leader in global financing for HIV/AIDS in the early phases of the pandemic and has contributed US$4.6 billion to programs related to the illness since 1989. Because of assistance from the Bank—more precisely, through the International Development Association—for 1,500 counseling and testing centers, about 7 million people have had HIV tests. Restraint Factor for the HIV Diagnostics Market Lack of Healthcare Infrastructure and Awareness to Limit the Sales A proper infrastructure for healthcare delivery is lacking in many areas, especially in poor nations, which makes it difficult to provide diagnostic services. This covers concerns with the supply chain, inadequate laboratory facilities, and skilled staff. It might be particularly difficult to access diagnostic services in rural and isolated places due to a lack of healthcare facilities and inadequate transportation infrastructure. Furthermore, HIV diagnosis rates are lower in the developing Asia-Pacific, Middle East, and African regions. These areas require a sufficient number of diagnostic facilities. Additionally, the diagnosis process needs to be explained to the majority of patients, which restricts market growth in these areas. Impact of Covid-19 on the HIV Diagnostics Market The COVID-19 pandemic has had a significant impact on the HIV diagnostics market, both in terms of challenges and opportunities. There was a decrease in HIV testing and diagnostic services during the pandemic as a result of the extensive healthcare resources being redirected to handle COVID-19. Some facilities were converted to provide COVID-19 treatment, and clinics and labs had a staffing crisis. Reduced HIV testing rates were the outcome of routine and community-based HIV testing programs being frequently halted to stop the spread of COVID-19. The adoption of telemedicine and remote healthcare services was expedited by the epidem...

In 2021, the number of new cases of HIV diagnosed in Spain amounted to 2,785 cases, 16 more new HIV cases than those reported a year prior. After peaking at over 4.4 thousand new HIV diagnoses in 2014, the number of new HIV infections in the European country showed an overall decline in the following years, reaching its lowest value of around 2.7 thousand new cases in 2020. As of 2021, the prevalence of HIV in Spain was 0.3 percent of the adult population between 15 and 49 years.

Background: The Investment Framework Enhanced (IFE) proposed in 2013 by the Joint United Nations Programme on HIV/AIDS (UNAIDS) explored how maximizing existing interventions and adding emerging prevention options, including a vaccine, could further reduce new HIV infections and AIDS-related deaths in low- and middle-income countries (LMICs). This article describes additional modeling which looks more closely at the potential health impact and cost-effectiveness of AIDS vaccination in LMICs as part of UNAIDS IFE. Methods: An epidemiological model was used to explore the potential impact of AIDS vaccination in LMICs in combination with other interventions through 2070. Assumptions were based on perspectives from research, vaccination and public health experts, as well as observations from other HIV/AIDS interventions and vaccination programs. Sensitivity analyses varied vaccine efficacy, duration of protection, coverage, and cost. Results: If UNAIDS IFE goals were fully achieved, new annual HIV infections in LMICs would decline from 2.0 million in 2014 to 550,000 in 2070. A 70% efficacious vaccine introduced in 2027 with three doses, strong uptake and five years of protection would reduce annual new infections by 44% over the first decade, by 65% the first 25 years and by 78% to 122,000 in 2070. Vaccine impact would be much greater if the assumptions in UNAIDS IFE were not fully achieved. An AIDS vaccine would be cost-effective within a wide range of scenarios. Interpretation: Even a modestly effective vaccine could contribute strongly to a sustainable response to HIV/AIDS and be cost-effective, even with optimistic assumptions about other interventions. Higher efficacy would provide even greater impact and cost-effectiveness, and would support broader access. Vaccine efficacy and cost per regimen are critical in achieving cost-effectiveness, with cost per regimen being particularly critical in low-income countries and at lower efficacy levels.

ODS / Goals and targets (from the 2030 Agenda for Sustainable Development) / Goal 3. Ensure healthy lives and promote well-being for all at all ages / Target 3.3. By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, waterborne diseases and other communicable diseases. / Indicator 3.3.1. Number of new HIV infections per 1,000 uninfected population, by sex, age and key populations

Romania RO: Incidence of HIV: per 1,000 Uninfected Population data was reported at 0.030 Ratio in 2022. This stayed constant from the previous number of 0.030 Ratio for 2021. Romania RO: Incidence of HIV: per 1,000 Uninfected Population data is updated yearly, averaging 0.040 Ratio from Dec 1990 (Median) to 2022, with 33 observations. The data reached an all-time high of 0.100 Ratio in 1991 and a record low of 0.030 Ratio in 2022. Romania RO: Incidence of HIV: per 1,000 Uninfected Population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Romania – Table RO.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates.;Weighted average;This is the Sustainable Development Goal indicator 3.3.1 [https://unstats.un.org/sdgs/metadata/].

The Department of Health prepares annual reports derived from the Information System on New HIV Infection Diagnoses in Aragon and the AIDS Case Registry. The Aragonese Institute of Statistics collects the data on cases of HIV and AIDS, elaborating the series of main indicators for Aragon disaggregated by provinces, sex, age, year of diagnosis, category of transmission and nationality.

Azerbaijan Incidence of HIV: per 1,000 Uninfected Population data was reported at 0.050 Ratio in 2022. This stayed constant from the previous number of 0.050 Ratio for 2021. Azerbaijan Incidence of HIV: per 1,000 Uninfected Population data is updated yearly, averaging 0.060 Ratio from Dec 1990 (Median) to 2022, with 33 observations. The data reached an all-time high of 0.110 Ratio in 2004 and a record low of 0.010 Ratio in 1993. Azerbaijan Incidence of HIV: per 1,000 Uninfected Population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Azerbaijan – Table AZ.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates.;Weighted average;This is the Sustainable Development Goal indicator 3.3.1 [https://unstats.un.org/sdgs/metadata/].